Back to Results
First PageMeta Content
Research / Clinical research / Clinical pharmacology / Therapeutics / Bioequivalence / Center for Drug Evaluation and Research / Drug discovery / Dermatologic and Ophthalmic Drugs Advisory Committee / Oncology Drug Advisory Committee / Pharmaceutical sciences / Pharmacology / Food and Drug Administration


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived
Add to Reading List

Open Document

File Size: 107,63 KB

Share Result on Facebook

City

Washington D.C. / /

Company

Ph.D. Nextcea Inc. / D. / /

Facility

Ph.D. West Virginia University / Ph.D. Duquesne University / Ph.D. University of Iowa LUNCH FOOD AND DRUG ADMINISTRATION / /

Organization

Duquesne University / office of New Drug Quality Assessment / Center for Drug Evaluation and Research / office of New Drugs / University of Iowa / office of Testing / Advisory Committee for Pharmaceutical Science / Division of Cardiovascular and Renal Products / U.S. Food and Drug Administration / West Virginia University / Advisory Committee for Pharmaceutical Science and Clinical Pharmacology / /

Person

Frank Hsieh / Acting Branch / Nakissa Sadrieh / Phospholipidosis Mark Reasor / Mansoor Khan / Sanofi-Aventis Topic / Perspectives Stephen Miller / Silver Spring Silver Spring / James Willard / Opening Remarks Elizabeth Topp / Perspective Kenneth Hastings / Demonstrating Dale Conner / Helen N. Winkle / /

Position

Director / Division of Bioequivalence Evaluation / Director / Division of Product Quality Research / Chair / Pharmacologist / Chief / Division of Pre-marketing Assessment / Director for Research Policy and Implementation / OPS / Designated Federal Official / Ph. Director / Division of Product Quality Research / M.P.H. Designated Federal Official / /

ProvinceOrState

Iowa / /

Region

West Virginia / /

SocialTag